Ruud Dings Institution-verified
Sourced from institutional research profiles (UAMS TRI or ARA).
Associate Professor
faculty
Radiation Oncology, College of Medicine
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Ruud Dings studies cellular immunotherapy, particularly in the context of dysbiosis. He is the Principal Investigator on a grant from the NIH/National Cancer Institute, totaling $348,182, which focuses on improving cellular immunotherapy during dysbiosis. His work in radiation oncology at the University of Arkansas for Medical Sciences contributes to the understanding and potential enhancement of cancer treatment modalities.
Dings maintains an active laboratory website, which likely serves as a platform for disseminating research findings and engaging with the scientific community. His research interests align with advancing therapeutic strategies within oncology and understanding the complex interplay of microbial environments and immune responses.
Federal Grants 1 $348,182 total
Improvement of cellular immunotherapy during dysbiosis- Resubmission
Grants & Funding
- Determination of functional and molecular biomarkers of treatment resistance with multimodal optical spectroscopy- Resubmission NIH/Nat. Cancer Institute - Pass Through: University of Arkansas at Fayetteville Principal Investigator
- In vivo, noninvasive, ultrasensitive photoacoustic detection of early breast cancer metastasis in bone US Department of the Army Principal Investigator
- Improvement of cellular immunotherapy during dysbiosis- Resubmission NIH Principal Investigator
- Center for Molecular Interactions in Cancer (CMIC) NIH Co-Investigator
- Antibiotic-Induced Dysbiosis Promotes Lung Metastasis US Department of Defense Principal Investigator
- Improvement of cellular immunotherapy during dysbiosis NIH/Nat. Cancer Institute Principal Investigator
- Determination of functional and molecular biomarkers of treatment resistance with multimodal optical spectroscopy- Resubmission NIH/Nat. Cancer Institute - Pass Through: University of Arkansas at Fayetteville Principal Investigator
- Improvement of cellular immunotherapy during dysbiosis NIH/Nat. Cancer Institute Principal Investigator
Frequent Collaborators
Similar Researchers
Based on overlapping research topics